Daiwa Securities Group
CALA

Daiwa Securities Group’s Calithera Biosciences, Inc CALA Stock Holding History

Daiwa Securities Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7
Closed – – 1477
2021
Q3 		$0 Hold
7
– – ﹤0.01% 1357
2021
Q2 		$0 Hold
7
– – ﹤0.01% 1301
2021
Q1 		$0 Hold
7
– – ﹤0.01% 1299
2020
Q4 		$1K Buy
+7
New +$614 ﹤0.01% 1243
2018
Q4 		– Sell
-10
Closed -$1K – 1206
2018
Q3 		$1K Hold
10
– – ﹤0.01% 1154
2018
Q2 		$1K Hold
10
– – ﹤0.01% 1174
2018
Q1 		$1K Buy
+10
New +$1.56K ﹤0.01% 1161

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Daiwa Securities Group's CALA Position: Q4 2021 in Review

Daiwa Securities Group sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 7 shares.

Daiwa Securities Group first reported a position in CALA in Q1 2018 and held it in 7 quarters. The position peaked at $1K in Q4 2020. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • Daiwa Securities Group reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 7 Calithera Biosciences, Inc shares in Q4 2021.
  • Daiwa Securities Group first reported a position in Calithera Biosciences, Inc in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Calithera Biosciences, Inc position peaked at $1K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.